Chair(s): Katerina Antoniou, Marlies S. Wijsenbeek, Antoine Froidure
Session type: State of the art session
Luca Richeldi
Session content
Failed idiopathic pulmonary fibrosis trials: lessons learned
Luca Richeldi
Replay
Slides
Yet Hong Khor
Replay
Slides
Manuela Funke-chambour
Replay
Slides
Bruno Crestani
Replay
Slides
Replay
Session aims
To focus on understanding the lessons learned from the failed trials and how drug development can be improved for IPF; to present novel endpoints different from forced vital capacity decline.